FTSE on a drugs high

clock

The FTSE 100 Index closed 43 points, or 0.7%, higher at 5,856 points today led by talk Novartis is lining up a bid for AstraZeneca.

AstraZeneca gained 4.35% to 2,832p. Royal & Sun Alliance was also a top riser, gaining 1.59% to 127.50p, after it reported a strong set of final figures after a "very good" year. The insurer registered a better than expected operating result of £698m. Sector peer Aviva gained 1.33% to 799.50p after UBS raised its share price target to 810p from 740p. BAE Systems was 1.32% higher at 421.75p following a report in The Guardian, which said EADS is lining up a bid for the UK group’s 20% stake in Airbus. Meanwhile, Tesco fell 0.90% to 329p following last night’s data from research fir...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

How quality investing behaves through the cycle

How quality investing behaves through the cycle

Resilience when it matters more

Joseph Stephens and Laura Neill
clock 14 September 2026 • 4 min read
Why portfolios need to evolve, not revolve when it comes to client outcomes

Why portfolios need to evolve, not revolve when it comes to client outcomes

'As market structures evolve, so must portfolio construction'

Ed Senior
clock 11 September 2026 • 4 min read
What does 'quality' investing actually mean?

What does 'quality' investing actually mean?

Why persistence is the real test

Joseph Stephens and Laura Neill
clock 11 September 2026 • 4 min read